CIK: 0001710065
Total reported value
—
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | Stock-Other | 74.71% | -84.07% | EXIT | |
| 2 | KYMR | Kymera Therapeutics INC | Stock-Other | 22.47% | -5.36% | EXIT | |
| 3 | SEER | Seer INC | Stock-Other | 1.57% | -5.06% | EXIT | |
| 4 | ✓ | Xilio Therapeutics INC | Stock-Other | 0.52% | — | — | |
| 5 | ✓ | Rallybio CORP | Stock-Other | 0.33% | — | — | |
| 6 | ✓ | Rapt Therapeutics INC | Stock-Other | 0.28% | — | — | |
| 7 | STRO | Sutro Biopharma, Inc. | Stock-Other | 0.13% | -1.43% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | KYMR | Kymera Therapeutics INC | +7.6% | — | Unchanged |
| 2 | ✓ | Rapt Therapeutics INC | +0.1% | — | Trim |
| 3 | STRO | Sutro Biopharma, Inc. | 0% | — | Unchanged |
| 4 | ✓ | Xilio Therapeutics INC | -0.1% | — | Unchanged |
| 5 | SEER | Seer INC | -0.1% | — | Unchanged |
| 6 | ✓ | Rallybio CORP | -0.3% | — | Unchanged |
| 7 | ACLXGBX | Arcellx INC | -7.1% | — | Unchanged |
| 8 | CARM | Carisma Therapeutics INC | — | EXIT | Sold out |